Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

The value of the serum tumour marker CA 125 to date has been in the monitoring of ovarian cancer patients for response to therapy and for recurrence of disease. However, despite the availability of serial data on CA 125, the problem of interpreting a change over time is still unsolved. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuxen, M K, Sölétormos, G, Dombernowsky, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363637/
https://www.ncbi.nlm.nih.gov/pubmed/11355938
http://dx.doi.org/10.1054/bjoc.2001.1787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363637/
https://www.ncbi.nlm.nih.gov/pubmed/11355938
http://dx.doi.org/10.1054/bjoc.2001.1787

Ejemplares similares